Dr Reddy's to spend upto $ 300 million on R&D in FY 20

The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the sales for the quarter, he said.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/30zZcGP
via Latest News of India